• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - GALWAY PROMUS ELEMENT ¿; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - GALWAY PROMUS ELEMENT ¿; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Model Number H7493911320300
Device Problem Occlusion Within Device (1423)
Patient Problem Reocclusion (1985)
Event Date 02/01/2017
Event Type  Injury  
Manufacturer Narrative
Device is a combination product.Device evaluated by mfr: it is indicated that the device will not be returned for evaluation.If there is any further relevant information obtained, a supplemental medwatch will be filed.(b)(4).
 
Event Description
(b)(6) study.It was reported that in-stent restenosis (isr) occurred.In (b)(6) 2013, the patient presented with an unstable angina and was referred for cardiac catheterization and index procedure was performed on the same day.The target lesion #1 was located in the proximal left anterior descending (lad) artery with 85% stenosis, and was 15 mm long with a reference vessel diameter of 4.0 mm.The lesion was treated with 4.00x16mm promus element ¿ drug-eluting stent (des) with 0% residual stenosis.The target lesion #2 was located in the mid lad with 95% stenosis, and was 20 mm long with a reference vessel diameter of 3.0 mm.The lesion was treated by pre- dilatation and placement of 3.00x20mm promus element ¿ des.Following post dilatation, the residual stenosis was 0%.Two days post procedure, the patient was discharged on aspirin and clopidogrel.In (b)(6) 2017, the patient was diagnosed with an isr in the mid lad and was hospitalized on the same day.After three days, coronary angiography was performed which revealed 80% stenosis in the mid lad.The isr noted was treated with percutaneous coronary intervention (pci) which reduced to 0%.One day post procedure, the outcome of the event was considered to be recovered/ resolved and the patient was discharged on the same day.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROMUS ELEMENT ¿
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC - GALWAY
Manufacturer (Section G)
BOSTON SCIENTIFIC - GALWAY
Manufacturer Contact
sonali arangil
one scimed place
maple grove, MN 55311
7634941700
MDR Report Key7347034
MDR Text Key102703708
Report Number2134265-2018-02087
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeCN
PMA/PMN Number
SIMILAR
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial
Report Date 02/27/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date05/03/2014
Device Model NumberH7493911320300
Device Catalogue Number39113-2030
Device Lot Number15752928
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 02/27/2018
Initial Date FDA Received03/16/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured01/02/2013
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age40 YR
-
-